Xiaolin Lin

1.8k total citations
45 papers, 1000 citations indexed

About

Xiaolin Lin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaolin Lin has authored 45 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 15 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Xiaolin Lin's work include MicroRNA in disease regulation (8 papers), RNA modifications and cancer (8 papers) and Cancer-related molecular mechanisms research (5 papers). Xiaolin Lin is often cited by papers focused on MicroRNA in disease regulation (8 papers), RNA modifications and cancer (8 papers) and Cancer-related molecular mechanisms research (5 papers). Xiaolin Lin collaborates with scholars based in China, United States and Norway. Xiaolin Lin's co-authors include Dong Xiao, Raoying Xie, Kang Xu, Jun-Shuang Jia, Junwen Shi, Sheng Yang, Shengchun Wang, Kai‐Tai Yao, Yujuan Qin and Lin Chen and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Xiaolin Lin

44 papers receiving 994 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolin Lin China 20 599 368 147 145 72 45 1000
N. Skuli United States 3 493 0.8× 389 1.1× 136 0.9× 92 0.6× 59 0.8× 6 969
Tao Zhao China 20 538 0.9× 400 1.1× 197 1.3× 131 0.9× 92 1.3× 30 937
Zhendong Yu China 17 638 1.1× 292 0.8× 132 0.9× 126 0.9× 126 1.8× 47 1.1k
Bakhtiar Yamini United States 20 487 0.8× 317 0.9× 158 1.1× 153 1.1× 85 1.2× 44 1.0k
Yuqing Zhang China 15 718 1.2× 340 0.9× 183 1.2× 115 0.8× 45 0.6× 22 1.0k
Wei Bao China 18 651 1.1× 393 1.1× 197 1.3× 117 0.8× 47 0.7× 35 1.1k
Xianwei Su China 20 857 1.4× 286 0.8× 185 1.3× 61 0.4× 83 1.2× 37 1.1k
An‐Chen Chang Taiwan 20 565 0.9× 275 0.7× 232 1.6× 129 0.9× 91 1.3× 37 947
Qinchuan Wang China 22 757 1.3× 288 0.8× 266 1.8× 191 1.3× 54 0.8× 50 1.3k
Renbing Jia China 9 682 1.1× 389 1.1× 154 1.0× 125 0.9× 45 0.6× 20 938

Countries citing papers authored by Xiaolin Lin

Since Specialization
Citations

This map shows the geographic impact of Xiaolin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Lin more than expected).

Fields of papers citing papers by Xiaolin Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Lin. The network helps show where Xiaolin Lin may publish in the future.

Co-authorship network of co-authors of Xiaolin Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolin Lin. A scholar is included among the top collaborators of Xiaolin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolin Lin. Xiaolin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Jingbo, Xiaolin Lin, Hongji Li, et al.. (2025). FoxO3 controls cardiomyocyte proliferation and heart regeneration by regulating Sfrp2 expression in postnatal mice. Nature Communications. 16(1). 2532–2532. 2 indexed citations
2.
Lin, Xiaolin, Jun‐Fang Lin, Yan Cao, et al.. (2024). Cardiomyocyte proliferation and heart regeneration in adult Xenopus tropicalis evidenced by a transgenic reporter line. npj Regenerative Medicine. 9(1). 40–40.
3.
Zhao, Shuqin, et al.. (2024). Gastrodin ameliorates diabetic nephropathy by activating the AMPK/Nrf2 pathway. Journal of Molecular Histology. 55(6). 1327–1339. 1 indexed citations
4.
Qin, Tianyu, Shuangxing Li, Xiaolin Lin, et al.. (2023). MicroRNA-155 suppressed cholesterol-induced matrix degradation, pyroptosis and apoptosis by targeting RORα in nucleus pulposus cells. Cellular Signalling. 107. 110678–110678. 15 indexed citations
5.
Zheng, Zhichao, Lihong Wu, Zhicong Li, et al.. (2023). Mir155 regulates osteogenesis and bone mass phenotype via targeting S1pr1 gene. eLife. 12. 5 indexed citations
6.
Kennedy, Lauritz, Vuk Palibrk, Wei Wang, et al.. (2022). Lactate receptor HCAR1 regulates neurogenesis and microglia activation after neonatal hypoxia-ischemia. eLife. 11. 47 indexed citations
7.
Sun, Yan, Xiaolin Lin, Bangdong Liu, et al.. (2021). Loss of ATF4 leads to functional aging-like attrition of adult hematopoietic stem cells. Science Advances. 7(52). eabj6877–eabj6877. 22 indexed citations
8.
9.
Zhang, Xiaoling, Zijian Li, Ying Zhou, et al.. (2021). MST4 negatively regulates the EMT, invasion and metastasis of HCC cells by inactivating PI3K/AKT/Snail1 axis. Journal of Cancer. 12(15). 4463–4477. 21 indexed citations
10.
Lin, Taoyan, Yan Chen, Jun-Shuang Jia, et al.. (2019). <p>Loss of Cirbp expression is correlated with the malignant progression and poor prognosis in nasopharyngeal carcinoma</p>. Cancer Management and Research. Volume 11. 6959–6969. 12 indexed citations
11.
Gu, Peng, Jun-Shuang Jia, Wei Liu, et al.. (2019). Optimization Strategy for Generating Gene-edited Tibet Minipigs by Synchronized Oestrus and Cytoplasmic Microinjection. International Journal of Biological Sciences. 15(12). 2719–2732. 5 indexed citations
12.
Xie, Raoying, Xiaolin Lin, Tao Du, et al.. (2016). Targeted Disruption of miR-17-92 Impairs Mouse Spermatogenesis by Activating mTOR Signaling Pathway. Medicine. 95(7). e2713–e2713. 55 indexed citations
13.
Jia, Jun-Shuang, Xiaolin Lin, Xia Lin, et al.. (2016). R/L, a double reporter mouse line that expresses luciferase gene upon Cre-mediated excision, followed by inactivation of mRFP expression. Genome. 59(10). 816–826. 4 indexed citations
14.
Backe, Paul Hoff, Mirta Mittelstedt Leal de Sousa, Zafar Iqbal, et al.. (2016). NovelUCHL1mutations reveal new insights into ubiquitin processing. Human Molecular Genetics. 26(6). ddw391–ddw391. 29 indexed citations
15.
Hu, Hongjuan, et al.. (2015). Upregulation of Sestrin2 Expression Protects Against Macrophage Apoptosis Induced by Oxidized Low-Density Lipoprotein. DNA and Cell Biology. 34(4). 296–302. 38 indexed citations
16.
Rong, Xiaoxiang, Wei Fang, Xiaolin Lin, et al.. (2015). Recognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognition. OncoImmunology. 5(3). e1086060–e1086060. 35 indexed citations
17.
Lin, Xiaolin, Jun-Shuang Jia, Tao Du, et al.. (2015). Overexpression of miR-155 in the Liver of Transgenic Mice Alters the Expression Profiling of Hepatic Genes Associated with Lipid Metabolism. PLoS ONE. 10(3). e0118417–e0118417. 53 indexed citations
18.
Wang, Shengchun, Xiaolin Lin, Jing Li, et al.. (2014). MicroRNA-122 Triggers Mesenchymal-Epithelial Transition and Suppresses Hepatocellular Carcinoma Cell Motility and Invasion by Targeting RhoA. PLoS ONE. 9(7). e101330–e101330. 101 indexed citations
19.
Du, Tao, Jun-Shuang Jia, Xiaolin Lin, et al.. (2013). Generation of Rm21LG transgenic mice: a powerful tool to generate conditional overexpression of miR-21 that is involved in oncogenesis. Biotechnology Letters. 36(1). 9–20. 10 indexed citations
20.
Lin, Xiaolin. (2011). Detection of BRCA1,CDH1,DKK1 and SFRP1 methylation in peripheral blood cells of patients with Metastatic breast cancer. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026